Afflux News Today

MyJournals.org - Science - IJMS, Vol. 24, Pages 9525: Efflux-Related Carbapenem Resistance in Acinetobacter baumannii Is Associated with Two-Component Regulatory Efflux Systems’ Alteration and Insertion of ΔAbaR25-Type Island Fragment (International Journal of Molecular Sciences)

Key Highlights: Continued progress has been made in advancing an investigator-initiated clinical trial to gain human proof-of-concept for Cholesterol Efflux Mediator™ VAR 200 in patients with... | May 12, 2023

ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney... | May 11, 2023

ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney... | May 9, 2023

Mr. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease and Inflammasome ASC Inhibitor IC 100... | April 11, 2023

MyJournals.org - Science - Molecules, Vol. 28, Pages 2912: Efflux Pump Inhibitors in Controlling Antibiotic Resistance: Outlook under a Heavy Metal Contamination Context (Molecules)

The sticky leaves of a native Australian shrub, used by the nations First Peoples as medicine, have been found to contain compounds that could possibly assist with cancer treatment.

Info La Roche sur Yon Vendée Un afflux dappels record chez les pompiers ce week-end du 15 août... La Roche sur Yon